Skip to content

Mescaline: all studies

Page 52 of 97: studies 511 to 520 of 963, newest first. Back to the mescaline overview

Research

EXPERIMENTALLY PRODUCED PSYCHOSES

American Journal of Psychiatry February 1, 1951 Paul H. Hoch 41 citations

Intravenous injection of synthetic mescaline was used in a group of schizophrenic patients and on "normal" voluntary controls. The changes produced by mescaline in "normals" were described. In addition, the observations were made that mescaline is able to underscore in patients suffering from schizophrenia their schizophrenic symptoms or able to precipitate schizophrenic psychoses in persons...

DOI: 10.1176/ajp.107.8.607 (opens in new tab) Mescaline Psychosurgery Schizophrenia object-oriented programming Psychosis +3

THE ELECTROENCEPHALOGRAM AND PSYCHOPATHOLOGICAL MANIFESTATIONS IN SCHIZOPHRENIA AS INFLUENCED BY DRUGS1

Psychosomatic Medicine October 1, 1942 Morton A. Rubin, William Malamud, Justin M. Hope 24 citations

Mescaline, cocaine, sodium amytal and benzedrine were given to 14 schizophrenic patients, and their influence upon personality functions and the electroencephalogram (EEG) was observed. Changes in the EEG were found only when definite psychological changes took place. The effects of the drugs could be classified into two types: 1) Those specific for a given drug. Psychologically these were...

Psychedelics and psychosis: A systematic review of recent-era studies (1984-2025).

Journal of Psychopharmacology October 27, 2026 José Augusto Silva Reis, Lara Zancaner Ueta, José Carlos Bouso et al.

This systematic review evaluates the relationship between classical psychedelic drugs (D-Lysergic acid N,N-diethylamide, psilocybin, ayahuasca/N-N-dimethyl-tryptamine, and mescaline) and the emergence of psychotic symptoms, aiming to synthesize evidence from contemporary studies (1984-2025) regarding the risk factors, prevalence, and clinical characteristics of psychosis related to psychedelic...

Psychedelics in neurosurgery: Potential utility in prevention, perioperative care, pain management, and neurorehabilitation

Surgical Neurology International October 9, 2026 Andrea Garcia-Bitar, Eduardo Jesus Castañeda, José Rafael Buenrostro-Rangel et al.

Background: Neurosurgical patients carry a high and frequently undertreated burden of psychological suffering, acute and chronic pain, and neurological deficits amenable to recovery. The resurgence of psychedelic research has produced relevant evidence in adjacent fields, but its applicability to neurosurgery has not been systematized. This review synthesizes that evidence across prevention,...

REDISCOVERING PEDRO ORTIZ CABANILLAS (1933-2011): PERUVIAN CYBERNETIC AND THE SOCIOBIOLOGICAL INFORMATIONAL THEORY.

Bio Systems October 1, 2026 Hans Contreras-Pulache

Pedro Ortiz Cabanillas (1933-2011), a Peruvian neurologist and professor at Universidad Nacional Mayor de San Marcos, spent five decades building an Sociobiological Informational Theory: a systematic account of the universe, life, and organized society built around a single, redefined concept -information- understood as a material structure exclusive to living systems. Two works anchor his...

The Plants That Remembered the Sky

Zenodo (CERN European Organization for Nuclear Research) September 23, 2026 Lisa M Wilkinson preprint

The Plants That Remembered the Sky: Sacred Landscapes, Mythic Plants and the Human Imagination Description This work explores recurring symbolic relationships between sacred plants, cosmology, landscape, memory and transformation across multiple Indigenous traditions of the Americas. Drawing upon mythological narratives, ethnographic records, archaeological findings and comparative symbolism,...

Cardiac Arrhythmia Associated with Psychoactive Drugs: An analysis of the FDA Adverse Event Reporting System

medRxiv September 10, 2026 Mori Krantz, Mark C. Haigney, Mary Ross Southworth et al. preprint

Background: Several Schedule I substances have demonstrated potential benefits for refractory psychiatric conditions and addiction. Some have been legalized at the state level, while others like kratom (mitragynine) are available over-the-counter in some states and illegal in others. A recent presidential executive order directs certain federal agencies to accelerate development and facilitate...

843. Not all who wander are lost – Might psychedelics alleviate neurodegeneration and depression in dementia?

The International Journal of Neuropsychopharmacology September 9, 2026 J Vieira-Andrade, I Marques, M Brito

Abstract Background Serotonin 2A receptor (5-HT2AR) agonists play a crucial role in multiple cognitive processes, namely executive functions, learning and memory. Owing partly to this, psychedelics such as lysergic acid diethylamide (LSD), psilocybin, dimethyltryptamine (DMT), mescaline and ayahuasca might be valuable adjuvants in improving memory deficits and language impairment. Thanks to...

Eveiller la conscience par le corps dans les cérémonies néo-shamanique

Editions des archives contemporaines eBooks September 3, 2026 Christian Ghasarian

Cette communication traite des représentations, discours et pratiques liés à l’absorption de plantes psychotropes, initialement employées dans les contextes shamaniques à travers le monde et désormais réappropriées dans le cadre d’une quête de soi dans les sociétés post-industrielles. Après un bref retour sur les circonstances socioculturelles et les raisons individuelles de ces investissements...

L'uomo metafisico - Sospensione del Weltbild e metamorfosi del mondo vissuto nell'esperienza mescalinica

Zenodo (CERN European Organization for Nuclear Research) August 25, 2026 Kevin Rauter preprint

This thesis investigates the mescaline experience as a peculiar and radical form of phenomenological reduction. It begins by examining the constitution of the human lived world through Wittgenstein's concept of Weltbild and Merleau-Ponty's phenomenology of perception and embodiment. The argument distinguishes between a pre-predicative, perceptual “first world” and a linguistically and...